Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Arlington Towers

Sep 20, 2022 7:00 AM - Sep 21, 2022 3:00 PM

950 N Stafford St., Arlington, VA 22203-1813, USA

Biosimilars Conference

Convening Professionals in Biosimilar Development to Discuss the Challenges of Today and the Possibilities of Tomorrow

Session 2a: So You Want to Develop a Biosimilar - Defining the Pipeline

Session Chair(s)

Leah  Christl, PhD

Leah Christl, PhD

Exec Director, Global Biosimilars Regulatory Affairs & Regulatory & R&D Policy

Amgen, United States

So, you’ve decided to get into the biosimilars business…now what? This session will focus on how manufacturers assess the potential of specific biosimilar assets and make decisions about their future pipeline. The session will address aspects such as asset selection drivers, portfolio considerations, and perspectives to consider related to patents. The session will also discuss the dynamics of penetrating the market, the reality of global biosimilar markets, and future market development.

Learning Objective :
  • Provide perspective as to why companies choose to develop certain biosimilars
  • Identify factors that drive the selection of a biosimilar asset
  • Understand the factors that drive decisions by manufacturers to ultimately bring or not bring a biosimilar to the market
  • Identify what is on the horizon for the next wave of biosimilar products
  • Understand the dynamics of penetrating the biosimilars marketplace

Speaker(s)

Chad  Pettit, MBA

Speaker

Chad Pettit, MBA

Amgen Inc., United States

Executive Director, Marketing, Global Biosimilars Commercial Lead

Balaji V Prasad, MD, MBA

Speaker

Balaji V Prasad, MD, MBA

Barclays, United States

Director, Specialty Pharma Equity Research

Rachel  Goode, PhD

Speaker

Rachel Goode, PhD

Fresenius Kabi , United States

Senior Vice President, IP and Legal, Biosimilars

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.